If Everyone Tripped on Psychedelics, We’d Do More About Climate Change
Scientists are looking into what psychedelics do to inspire people to act pro-environmentally.
Hallucinogenic Fungi Turn Cicadas Into Sex-Crazed Zombies
When cicadas are infected with this fungus, they lose control of their bodies and mate with anything they can find.
The Movement to Make Shrooms Legal Is Gaining Momentum
Denver just decriminalized the drug, and Oakland could be next.
The Ethics of Taking the Drugs You Study
Should psychedelic scientists trip on the drugs they research?
The Dramatic Story of How Denver Decriminalized Mushrooms
With a little help from Joe Rogan and the youth vote, the almost unthinkable happened—and set the stage for reform nationwide.
When Psychedelics Make Your Last Months Alive Worth Living
“I am at peace with what’s next. The more I prepare to say goodbye, the more at peace I become with that reality."
An Australian Hospital Will Trial Magic Mushroom Therapy for Dying Patients
Australia's first shroom trial is set to take place at Melbourne's St. Vincent's Hospital in April.
What One Man Learned When He Treated His Autism Symptoms With Shrooms
"That trip was like an '80s movie starring me. I saw what my life could be like, without computers and all that rubbish. It gave me the most hope I've ever known."
The Burnout and Escapism Issue
The resurgence in clinical trials into the effectiveness of LSD, MDMA, and psilocybin in treating depression and trauma has received widespread publicity. But outside the labs, regular people are taking psychedelic therapy into their own hands.
Magic mushrooms are one step closer to decriminalization in Denver and Oregon
Marijuana-friendly hubs like Denver and Oregon could finally have a shot at decriminalizing psilocybin.
Here Comes the Legal Case for Medicinal Psychedelics
Therapist Bruce Tobin is striving to give end-of-life cancer patients magic mushrooms in a clinical setting.
Researchers Want Doctors to Be Able to Prescribe Magic Mushrooms for Depression
A new study out of Johns Hopkins University seeks to reclassify psilocybin mushrooms since they have low potential for abuse and few risks of dependence.